In this study, we found that GIPC1 reduced TTC7B ubiquitination by decreasing the expression of TRIM21, which helped maintain TTC7B protein expression and inhibited the mTOR/NF-κB signaling pathway in CRC cells, thereby suppressing CRC progression and chemotherapy resistance. Here, MTOR is linked to colorectal carcinoma.